fake drugs, ineffective, out-dated are the delight of merchants of venom and cynical speculators. The whole background of interests and resentments of those who should oversee
from What's Up in July 2009
Recently a shipment of anti-malarial drugs has arrived in Nigeria. The labels reading "Made in India", but health authorities in Nigeria have know that the products were actually Chinese. The incident has caused strong protests from New Delhi where the government has explicitly demanded an official apology from Beijing. The problem has been presented both from a humanitarian aspect and, more especially, and economics. China and India are fighting for a long time to open the share of African trade of medicines that hides behind the apparent veil of humanitarian aid, geopolitical and economic interests not just. Both nations are in fact looking for a substantial opening of trade with the continent and marketing of medicinal products to those countries, like Nigeria, full of key raw materials, it is worth a lot to the economic agreements. The comparison is based on the fact that Indian and Chinese medicines are sold in the continent at prices lower than those of Western multinationals, which, of their par, 
not miss an opportunity to highlight how those products are not following the rules of the World Health Organization. The WHO, in fact, announced that according to one study, nearly 60% of the drugs that enter the African continent are unnecessary, ineffective or even expired and more than 30% are counterfeit. Just industries of some pharmaceutical products at savings come with obvious consequences on their effectiveness and are not in a few volunteer doctors in Africa who tell of situations where you have to satisfy also of drugs of dubious origin could not be better. Moreover, it is normal that in a world where the controls are very few, if any, the market for fake drugs are freedom of action, and China is being the largest producer. Chinese products come from factories often not suitable for use with active or non-existent, others are simple mixtures of water, flour and sugar are not uncommon in cases where toxic agents were detected. In Beijing they are trying to control this illicit market. In 2007, three officers of the Department for the registration of drugs have been indicted for corruption by drug companies seeking quick approval of a their products. Nevertheless, the Chinese administration struggles to control the phenomenon.
is easy to understand, then, the anger of the Indians to learn that drugs are clearly of criminal origin on the African market ended with the words "Made in India" and resentment mounts even more when they discover that they come to New Delhi China's own, their main rival business in the region. On the website of the Press was the Indian government issued a statement attacking veiled but clear words, Beijing. "The Indian High Commission in Nigeria - it says - has advised that the delivery of tablets containing Maloxina and Amal used in the treatment of malaria was estimated 32.1 million Naira (Nigerian currency, approximately € 155 thousand) and were produced, packaged and shipped by sea from China. " In the statement, the Indian government confirms its concern to Beijing to offer more attention to the problem and take action against those "evil" (slander) the name of India in this field. The note concludes in New Delhi reiterated its position on the issue of trade in drugs, "India has acquired a strong position as a manufacturer and exporters of cheap drugs which have curative properties of their patented alternative - the reference is to the multinationals - but with much more reasonable cost. Generic medications used to treat poor people who can not afford patented drugs and brand, extremely expensive, the majority of multinational companies belonging to developed countries. "
they will not be an episode like this to improve the overall quality of medicines sold in Africa. The almost total lack of controls and the despair of the population are in fact the most prosperous land for those who despise life totally in favor of easy money.
not miss an opportunity to highlight how those products are not following the rules of the World Health Organization. The WHO, in fact, announced that according to one study, nearly 60% of the drugs that enter the African continent are unnecessary, ineffective or even expired and more than 30% are counterfeit. Just industries of some pharmaceutical products at savings come with obvious consequences on their effectiveness and are not in a few volunteer doctors in Africa who tell of situations where you have to satisfy also of drugs of dubious origin could not be better. Moreover, it is normal that in a world where the controls are very few, if any, the market for fake drugs are freedom of action, and China is being the largest producer. Chinese products come from factories often not suitable for use with active or non-existent, others are simple mixtures of water, flour and sugar are not uncommon in cases where toxic agents were detected. In Beijing they are trying to control this illicit market. In 2007, three officers of the Department for the registration of drugs have been indicted for corruption by drug companies seeking quick approval of a their products. Nevertheless, the Chinese administration struggles to control the phenomenon. is easy to understand, then, the anger of the Indians to learn that drugs are clearly of criminal origin on the African market ended with the words "Made in India" and resentment mounts even more when they discover that they come to New Delhi China's own, their main rival business in the region. On the website of the Press was the Indian government issued a statement attacking veiled but clear words, Beijing. "The Indian High Commission in Nigeria - it says - has advised that the delivery of tablets containing Maloxina and Amal used in the treatment of malaria was estimated 32.1 million Naira (Nigerian currency, approximately € 155 thousand) and were produced, packaged and shipped by sea from China. " In the statement, the Indian government confirms its concern to Beijing to offer more attention to the problem and take action against those "evil" (slander) the name of India in this field. The note concludes in New Delhi reiterated its position on the issue of trade in drugs, "India has acquired a strong position as a manufacturer and exporters of cheap drugs which have curative properties of their patented alternative - the reference is to the multinationals - but with much more reasonable cost. Generic medications used to treat poor people who can not afford patented drugs and brand, extremely expensive, the majority of multinational companies belonging to developed countries. "
they will not be an episode like this to improve the overall quality of medicines sold in Africa. The almost total lack of controls and the despair of the population are in fact the most prosperous land for those who despise life totally in favor of easy money.
0 comments:
Post a Comment